Dare Bioscience, Inc. Earnings Per Share, Basic and Diluted
Dare Bioscience, Inc. (DARE) reported Earnings Per Share, Basic and Diluted of -$0.16 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-13
- Dare Bioscience, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.16.
- Dare Bioscience, Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.22.
- Dare Bioscience, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.24.
- Dare Bioscience, Inc. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.27.
- Dare Bioscience, Inc. earnings per share, basic and diluted for fiscal 2020 was -$0.91.
- Dare Bioscience, Inc. earnings per share, basic and diluted for fiscal 2019 was -$0.97.
- Dare Bioscience, Inc. earnings per share, basic and diluted for fiscal 2018 was -$1.57, a 144.10% decline from fiscal 2017.
- Dare Bioscience, Inc. earnings per share, basic and diluted for fiscal 2017 was $3.56.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed | Earnings Per Share, Basic and Diluted 100 month |
|---|---|---|---|---|---|---|---|---|---|
| 2021-03-31 | -$0.16 10-Q · filed 2021-05-13 | ||||||||
| 2020-12-31 | -$0.22 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$0.46 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$0.72 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$0.91 10-K · filed 2021-03-30 | |||||
| 2020-09-30 | -$0.24 10-Q · filed 2020-11-12 | -$0.50 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$0.69 10-Q · filed 2020-11-12 | ||||||
| 2020-06-30 | -$0.27 10-Q · filed 2020-08-12 | -$0.45 10-Q · filed 2020-08-12 | |||||||
| 2020-03-31 | -$0.18 10-Q · filed 2021-05-13 | ||||||||
| 2019-12-31 | -$0.21 derived: net income ÷ weighted average shares · filed 2021-03-30 | -$0.42 derived: net income ÷ weighted average shares · filed 2021-03-30 | -$0.71 derived: net income ÷ weighted average shares · filed 2021-03-30 | -$0.97 10-K · filed 2021-03-30 | |||||
| 2019-09-30 | -$0.20 10-Q · filed 2020-11-12 | -$0.50 derived: net income ÷ weighted average shares · filed 2020-11-12 | -$0.76 10-Q · filed 2020-11-12 | ||||||
| 2019-06-30 | -$0.29 10-Q · filed 2020-08-12 | -$0.57 10-Q · filed 2020-08-12 | |||||||
| 2019-03-31 | -$0.27 10-Q · filed 2020-05-14 | ||||||||
| 2018-12-31 | -$0.26 derived: net income ÷ weighted average shares · filed 2020-03-27 | -$0.48 derived: net income ÷ weighted average shares · filed 2020-03-27 | -$0.79 derived: net income ÷ weighted average shares · filed 2020-03-27 | -$1.57 10-K · filed 2020-03-27 | $1.57 10-K · filed 2019-04-01 | ||||
| 2018-09-30 | -$0.23 10-Q · filed 2019-11-12 | -$0.54 derived: net income ÷ weighted average shares · filed 2019-11-12 | -$1.32 10-Q · filed 2019-11-12 | ||||||
| 2018-06-30 | -$0.32 10-Q · filed 2019-08-14 | -$1.13 10-Q · filed 2019-08-14 | |||||||
| 2018-03-31 | -$0.88 10-Q · filed 2019-05-14 | ||||||||
| 2017-12-31 | $3.56 10-K · filed 2019-04-01 | -$3.56 10-K · filed 2018-03-28 | |||||||
| 2017-09-30 | -$0.33 10-Q · filed 2018-11-13 | -$1.04 10-Q · filed 2018-11-13 | |||||||
| 2017-06-30 | -$0.55 10-Q · filed 2018-08-13 | -$1.42 10-Q · filed 2017-08-14 | -$0.82 10-Q · filed 2018-08-13 | -$3.61 10-Q · filed 2017-08-14 | |||||
| 2017-03-31 | -$0.27 10-Q · filed 2018-05-14 | -$0.22 10-Q · filed 2017-05-12 | |||||||
| 2016-12-31 | -$0.17 10-K/A · filed 2017-06-13 | -$0.81 10-K · filed 2018-03-28 | -$1.42 10-K · filed 2017-03-31 | ||||||
| 2016-09-30 | -$0.02 10-Q · filed 2017-11-13 | -$0.36 10-Q · filed 2016-11-03 | -$0.58 10-Q · filed 2017-11-13 | -$1.26 10-Q · filed 2016-11-03 | |||||
| 2016-06-30 | -$3.97 10-Q · filed 2017-08-14 | -$0.40 10-Q · filed 2016-08-04 | -$8.92 10-Q · filed 2017-08-14 | -$0.89 10-Q · filed 2016-08-04 | |||||
| 2016-03-31 | -$0.49 10-K/A · filed 2017-06-13 | ||||||||
| 2015-12-31 | -$0.39 10-K/A · filed 2017-06-13 | -$1.56 10-K/A · filed 2017-06-13 | |||||||
| 2015-09-30 | -$0.39 10-K/A · filed 2017-06-13 | -$1.17 10-Q · filed 2016-11-03 | |||||||
| 2015-06-30 | -$0.37 10-K/A · filed 2017-06-13 | -$0.78 10-Q · filed 2016-08-04 | -$1.15 derived: net income ÷ weighted average shares · filed 2017-06-13 | -$1.44 derived: net income ÷ weighted average shares · filed 2017-06-13 | |||||
| 2015-03-31 | -$0.41 10-K/A · filed 2017-06-13 | -$0.79 derived: net income ÷ weighted average shares · filed 2017-06-13 | -$1.06 derived: net income ÷ weighted average shares · filed 2017-06-13 | -$1.49 derived: net income ÷ weighted average shares · filed 2017-06-13 | |||||
| 2014-12-31 | -$0.37 10-K · filed 2016-03-10 | -$0.65 derived: net income ÷ weighted average shares · filed 2016-03-10 | -$1.07 derived: net income ÷ weighted average shares · filed 2016-03-10 | -$1.60 10-K/A · filed 2017-06-13 | |||||
| 2014-09-30 | -$0.28 10-K · filed 2016-03-10 | -$0.70 derived: net income ÷ weighted average shares · filed 2016-03-10 | -$1.26 10-Q · filed 2015-11-16 | -$2.01 derived: net income ÷ weighted average shares · filed 2016-03-10 | |||||
| 2014-06-30 | -$0.44 10-K · filed 2016-03-10 | -$1.17 10-Q · filed 2015-08-06 | -$2.24 derived: net income ÷ weighted average shares · filed 2016-03-10 | -$3.54 derived: net income ÷ weighted average shares · filed 2016-03-10 | |||||
| 2014-03-31 | -$3.70 10-K · filed 2016-03-10 | -$8.15 derived: net income ÷ weighted average shares · filed 2016-03-10 | -$12.53 derived: net income ÷ weighted average shares · filed 2016-03-10 | -$19.90 derived: net income ÷ weighted average shares · filed 2016-03-10 | -$167.93 10-Q · filed 2014-05-27 | ||||
| 2013-12-31 | -$4.45 10-K · filed 2015-03-19 | -$8.85 derived: net income ÷ weighted average shares · filed 2015-03-19 | -$16.34 derived: net income ÷ weighted average shares · filed 2015-03-19 | -$25.05 10-K · filed 2016-03-10 | |||||
| 2013-09-30 | -$4.40 10-K · filed 2015-03-19 | -$12.06 derived: net income ÷ weighted average shares · filed 2015-03-19 | -$20.96 10-Q · filed 2014-11-13 | ||||||
| 2013-06-30 | -$7.96 10-K · filed 2015-03-19 | -$17.05 10-Q · filed 2014-08-12 | |||||||
| 2013-03-31 | -$9.09 10-K · filed 2015-03-19 | ||||||||
| 2012-12-31 | -$36.39 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |